Oncologic Therapy Support Via Means of a Dedicated Mobile App (OPTIMISE-1)

Heidelberg University

Status

Unknown

Conditions

Breast Cancer

Thoracic Neoplasm

Quality of Life

Satisfaction

Radiotherapy; Complications

Oncologic Disorders

Pelvic Neoplasm

Treatments

Other: mobile application

Study type

Interventional

Funder types

Other

Identifiers

NCT03168048

OPTIMISE-1

Details and patient eligibility

About

The present single-center prospective exploratory study, conducted at Heidelberg University Hospital, assesses the feasibility of introducing a concept for additional patient care based on a mobile application for patients undergoing radiotherapy. Patients presenting themselves for the irradiation of thoracic or pelvic tumors will be surveyed regarding general performance, treatment-related Quality of Life (QoL) and symptoms and their need to personally consult a physician on a treatment-daily basis by means of a mobile application. The primary endpoint of feasibility will be reached when 80% of the patients have successfully answered 80% of their respective questions scheduled for each treatment day. Furthermore, treatment-related patient satisfaction and diagnosis-related QoL is assessed by PSQ-18 and EORTC questionnaires at the end of radiotherapy and at the first follow-up.

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Indication for radiotherapy with potentially curative intent of a primarily thoracic or pelvic target
Karnofsky performance score (KPS) ≥ 70%,
Ability to initiate the therapy as an outpatient
≥ 18 years of age

Exclusion criteria